Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Testicular cancer

Underestimating radiotherapy toxicity for stage I seminoma

Nature Reviews Urology volume 9, pages 241–242 (2012)Cite this article

Subjects

A recent survey of radiation oncologists has evaluated barriers to surveillance rather than adjuvant therapy for postorchiectomy management of stage I seminoma. The findings suggest that providers are underestimating the late toxicity of radiation therapy in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mead, G. M. et al. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up. J. Natl Cancer Inst. 103, 241–249 (2011).

    Article  Google Scholar 

  2. Daugaard, G., Petersen, P. M. & Rorth, M. Surveillance in stage I testicular cancer. APMIS 111, 76–85 (2003).

    Article  Google Scholar 

  3. Tandstad, T. et al. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. J. Clin. Oncol. 29, 719–725 (2011).

    Article  Google Scholar 

  4. Groll, R. J., Warde, P. & Jewett, M. A. A comprehensive systematic review of testicular germ cell tumor surveillance. Crit. Rev. Oncol. Hematol. 64, 182–197 (2007).

    Article  CAS  Google Scholar 

  5. Travis, L. B. et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J. Natl Cancer Inst. 97, 1354–1365 (2005).

    Article  Google Scholar 

  6. Zagars, G. K., Ballo, M. T., Lee, A. K. & Strom, S. S. Mortality after cure of testicular seminoma. J. Clin. Oncol. 22, 640–647 (2004).

    Article  Google Scholar 

  7. Arvold, N. D. et al. Barriers to the implementation of surveillance for stage I testicular seminoma. Int. J. Radiat. Oncol. Biol. Phys. http://dx.doi.org/10.1016/j.ijrobp.2011.11.064

  8. Vossen, C. Y., Horwich, A., Daugaard, G., van Poppel, H. & Osanto, S. Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int. doi:10.1111/j.1464-410X.2011.10887.x.

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology and Oncology, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, 19104, PA, USA

    Nicklas Pfanzelter

  2. Department of Radiation Oncology, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, 19104, PA, USA

    Justin E. Bekelman

Authors
  1. Nicklas Pfanzelter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Justin E. Bekelman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justin E. Bekelman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfanzelter, N., Bekelman, J. Underestimating radiotherapy toxicity for stage I seminoma. Nat Rev Urol 9, 241–242 (2012). https://doi.org/10.1038/nrurol.2012.78

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.78

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer